Recent Finacing
Recent Raise
Cellenkos is a Houston clinical-stage biotech developing off-the-shelf, cord blood–derived, tissue-directed allogeneic Treg therapies via its CRANE platform, with in-house cGMP manufacturing and cryopreserved on-demand doses.
